SOD1 and amyotrophic lateral sclerosis: For SOD1 ALS, it may be possible to use CRISPR-Cas9 genome editing to correct specific disease-causing mutations, delete the mutant SOD1 gene, or introduce strategic mutations to disable the mutant SOD1 function.